Immunogenicity, Safety and Consistency Of New Trivalent Inactivated Influenza Vaccine

To augment the available influenza vaccine supply, a phase III study was conducted to evaluate the immunogenicity, safety, and consistency of a new trivalent inactivated influenza vaccine manufactured by CSL Limited. Healthy adults (ages 18–64) were randomized to receive either a single dose of TIV...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Talbot, H. Keipp, Keitel, Wendy, Cate, Thomas R., Treanor, John, Campbell, James, Brady, Rebecca C., Graham, Irene, Dekker, Cornelia L., Ho, Dora, Winokur, Patricia, Walter, Emmanuel, Bennet, Jillian, Formica, Neil, Hartel, Gunter, Skeljo, Maryanne, Edwards, Kathryn M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605420/
https://ncbi.nlm.nih.gov/pubmed/18602726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.05.024
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky